On November 5, 2020, Ryan O’Neil spoke at DRI’s Drug and Medical Device Seminar, which continues to be the “go-to” event for in-house and outside counsel to the pharmaceutical and medical device industry.  Mr. O’Neil spoke about the differences between 510(k) and PMA regulatory pathways and how that distinction is critical to defending medical device cases.  The presentation included discussion of preemption, Comment k, and punitive damages statutes while providing practical takeaways on how regulatory experts can help shape and refine legal defense strategies.  Mr. O’Neil was invited to speak in light of his extensive experience defending manufacturers of medical devices in product liability cases nationwide.